A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis
Clinical trial NCT05728489 · COMPLETED
Trial details
- NCT number
- NCT05728489
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-27
- Primary completion
- 2025-02-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.